Yang et al. evaluated synergistic antitumor activity of replication-competent adenovirus armed with IL-18 against melanoma and found that it synergistically inhibited the melanoma cells growth and inhibited the vascular endothelial growth factor expression [24]. This evidence concerns the gene VEGFA and melanoma.